IRCT20150107020592N26已完成3 期
Favipiravir effectiveness in patients undergoing COVID19 Acute respiratory distress syndrome (ARDS)
Masih Daneshvari Hospital0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 no limit（—）
- 性别
- All
入选标准
- •Positive covid patients
- •Patients with a pao2 to fio2 ratio below 300
- •Age over 18 years
排除标准
- •Lack of desire to enter the plan
研究者
相似试验
招募中
3 期
The therapeutic effect of Favipiravir in COVID-19 patientsIRCT20211004052664N1Shahid Beheshti University of Medical Sciences80
招募中
3 期
Evaluation the effects of Favipiravir in COVID-19 patientsCOVID-19 pneumonia.COVID-19, virus identifiedU07.1IRCT20151227025726N14Shahid Beheshti University of Medical Sciences84
已完成
不适用
The Real-world Clinical Outcomes of Favipiravir Treatment in Mild to Moderate COVID-19 Patients in Single Outpatient Visit Followed by Home Isolation: a Multicenter, case-control StudyTCTR20221113004Chulabhorn Royal Academy1,037
已完成
不适用
Clinical study of favipiravir for patients with severe fever with thrombocytopenia syndrome 2017severe fever with thrombocytopenia syndromeJPRN-UMIN000029020Ehime University Hospital10
已完成
不适用
Clinical study of favipiravir for patients with severe fever with thrombocytopenia syndromesevere fever with thrombocytopenia syndromeJPRN-UMIN000022398Ehime University Hospital25